208 related articles for article (PubMed ID: 10082209)
1. Inhibition of P-selectin attenuates neutrophil-mediated myocardial dysfunction in isolated rat heart.
Ohnishi M; Yamada K; Morooka S; Tojo SJ
Eur J Pharmacol; 1999 Feb; 366(2-3):271-9. PubMed ID: 10082209
[TBL] [Abstract][Full Text] [Related]
2. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins.
Lefer AM; Campbell B; Scalia R; Lefer DJ
Circulation; 1998 Sep; 98(13):1322-8. PubMed ID: 9751682
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL
Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739
[TBL] [Abstract][Full Text] [Related]
4. Effects of a monoclonal antibody to P-selectin on recovery of neonatal lamb hearts after cold cardioplegic ischemia.
Nagashima M; Shin'oka T; Nollert G; Shum-Tim D; Hickey PR; Roth SJ; Kirchhoff A; Springer TA; Burke PR; Mayer JE
Circulation; 1998 Nov; 98(19 Suppl):II391-7; discussion II397-8. PubMed ID: 9852932
[TBL] [Abstract][Full Text] [Related]
5. Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion.
Lefer AM; Campbell B; Shin YK
J Mol Cell Cardiol; 1998 Dec; 30(12):2561-6. PubMed ID: 9990528
[TBL] [Abstract][Full Text] [Related]
6. A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion.
Lefer DJ; Flynn DM; Phillips ML; Ratcliffe M; Buda AJ
Circulation; 1994 Nov; 90(5):2390-401. PubMed ID: 7525107
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.
Lefer AM; Campbell B; Shin YK; Scalia R; Hayward R; Lefer DJ
Circulation; 1999 Jul; 100(2):178-84. PubMed ID: 10402448
[TBL] [Abstract][Full Text] [Related]
8. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
[TBL] [Abstract][Full Text] [Related]
9. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion.
Lefer DJ; Flynn DM; Buda AJ
Am J Physiol; 1996 Jan; 270(1 Pt 2):H88-98. PubMed ID: 8769738
[TBL] [Abstract][Full Text] [Related]
10. A sialyl Lewis(x)-containing carbohydrate reduces infarct size: role of selectins in myocardial reperfusion injury.
Flynn DM; Buda AJ; Jeffords PR; Lefer DJ
Am J Physiol; 1996 Nov; 271(5 Pt 2):H2086-96. PubMed ID: 8945929
[TBL] [Abstract][Full Text] [Related]
11. P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion.
Arai M; Masui Y; Goldschmidt-Clermont P; DiPaula A; Siu C; Kondo T; Becker LC
J Am Coll Cardiol; 1999 Jul; 34(1):280-8. PubMed ID: 10400022
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog.
Chen LY; Nichols WW; Hendricks JB; Yang BC; Mehta JL
Cardiovasc Res; 1994 Sep; 28(9):1414-22. PubMed ID: 7525063
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of P-selectin and ICAM-1 reduces myocardial injury following ischemia and reperfusion.
Lefer DJ; Flynn DM; Anderson DC; Buda AJ
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2421-9. PubMed ID: 8997301
[TBL] [Abstract][Full Text] [Related]
14. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.
Weyrich AS; Ma XY; Lefer DJ; Albertine KH; Lefer AM
J Clin Invest; 1993 Jun; 91(6):2620-9. PubMed ID: 7685773
[TBL] [Abstract][Full Text] [Related]
15. Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation.
Verma S; Maitland A; Weisel RD; Fedak PW; Pomroy NC; Li SH; Mickle DA; Li RK; Rao V
J Thorac Cardiovasc Surg; 2002 Jun; 123(6):1074-83. PubMed ID: 12063453
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion.
Campbell B; Chuhran CM; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1999 Oct; 21(8):529-34. PubMed ID: 10599051
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of citrulline in ischemia/reperfusion injury via a non-nitric oxide-mediated mechanism.
Ikeda Y; Young LH; Scalia R; Lefer AM
Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):563-71. PubMed ID: 11196344
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of neutrophil-mediated myocardial ischemia-reperfusion injury by a calpain inhibitor.
Ikeda Y; Young LH; Lefer AM
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1421-6. PubMed ID: 11893579
[TBL] [Abstract][Full Text] [Related]
19. Myocardial and endothelial protection by TMS in ischemia-reperfusion injury.
Murohara T; Buerke M; Margiotta J; Ruan F; Igarashi Y; Hakomori S; Lefer AM
Am J Physiol; 1995 Aug; 269(2 Pt 2):H504-14. PubMed ID: 7544541
[TBL] [Abstract][Full Text] [Related]
20. The blood contribution to early myocardial reperfusion injury is amplified in diabetes.
McDonagh PF; Hokama JY; Copeland JG; Reynolds JM
Diabetes; 1997 Nov; 46(11):1859-67. PubMed ID: 9356037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
